These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20521379)

  • 21. A novel ex vivo immunoproteomic approach characterising Fasciola hepatica tegumental antigens identified using immune antibody from resistant sheep.
    Cameron TC; Cooke I; Faou P; Toet H; Piedrafita D; Young N; Rathinasamy V; Beddoe T; Anderson G; Dempster R; Spithill TW
    Int J Parasitol; 2017 Aug; 47(9):555-567. PubMed ID: 28455238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes.
    Rojas-Caraballo J; López-Abán J; Pérez del Villar L; Vizcaíno C; Vicente B; Fernández-Soto P; del Olmo E; Patarroyo MA; Muro A
    PLoS One; 2014; 9(8):e105323. PubMed ID: 25122166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A recombinant thioredoxin-glutathione reductase from Fasciola hepatica induces a protective response in rabbits.
    Maggioli G; Silveira F; Martín-Alonso JM; Salinas G; Carmona C; Parra F
    Exp Parasitol; 2011 Dec; 129(4):323-30. PubMed ID: 21985914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adoptive transfer of dendritic cells pulsed with Fasciola hepatica antigens and lipopolysaccharides confers protection against fasciolosis in mice.
    Falcón CR; Carranza FA; Aoki P; Motrán CC; Cervi L
    J Infect Dis; 2012 Feb; 205(3):506-14. PubMed ID: 21949043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of protective efficacy in buffaloes vaccinated with Fasciola gigantica leucine aminopeptidase and peroxiredoxin recombinant proteins.
    Raina OK; Nagar G; Varghese A; Prajitha G; Alex A; Maharana BR; Joshi P
    Acta Trop; 2011 Jun; 118(3):217-22. PubMed ID: 21376699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination against Fasciola hepatica using cathepsin L3 and B3 proteases delivered alone or in combination.
    Wesołowska A; Basałaj K; Norbury LJ; Sielicka A; Wędrychowicz H; Zawistowska-Deniziak A
    Vet Parasitol; 2018 Jan; 250():15-21. PubMed ID: 29329618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fasciola hepatica: host responders and nonresponders to parasite glutathione S-transferase.
    Hillyer GV; Soler de Galanes M; Battisti G
    Exp Parasitol; 1992 Sep; 75(2):176-86. PubMed ID: 1516666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection.
    Azizi H; Mirzaeei H; Nasiri AA; Bazi A; Mirzapour A; Khatami M; Nahavandi KH; Azimi A; Yaghoobi H
    Exp Parasitol; 2018 Jun; 189():66-71. PubMed ID: 29729492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood leukocyte responses in rats vaccinated with cDNA encoding glutathioinie-S-transferase of Fasciola hepatica.
    Wedrychowicz I; Jedlina-Panasiuk L; Szymanski P; Bieńkowska-Szewczyk K
    Wiad Parazytol; 2001; 47(4):551-7. PubMed ID: 16886389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep.
    Maggioli G; Acosta D; Silveira F; Rossi S; Giacaman S; Basika T; Gayo V; Rosadilla D; Roche L; Tort J; Carmona C
    Vaccine; 2011 Nov; 29(48):9057-63. PubMed ID: 21939713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attempted immunisation of sheep against Fasciola hepatica using gamma-irradiated metacercariae.
    Creaney J; Spithill TW; Thompson CM; Wilson LR; Sandeman RM; Parsons JC
    Int J Parasitol; 1995 Jul; 25(7):853-6. PubMed ID: 7558572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection against Fasciola gigantica infection in mice by vaccination with recombinant juvenile-specific cathepsin L.
    Sansri V; Meemon K; Changklungmoa N; Kueakhai P; Chantree P; Chaichanasak P; Lorsuwannarat N; Itagaki T; Sobhon P
    Vaccine; 2015 Mar; 33(13):1596-601. PubMed ID: 25701317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the immune response of male and female rats vaccinated with cDNA encoding a cysteine proteinase of Fasciola hepatica (FhPcW1).
    Wesołowska A; Norbury LJ; Januszkiewicz K; Jedlina L; Jaros S; Zawistowska-Deniziak A; Zygner W; Wędrychowicz H
    Acta Parasitol; 2013 Jun; 58(2):198-206. PubMed ID: 23666656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of immunologic response in rats immunized orally or intramuscularly with cDNA and recombinant protein of the S-glutathione transferase from Fasciola Hepatica].
    Panasiuk LJ
    Wiad Parazytol; 2004; 50(4):757-8. PubMed ID: 16862814
    [No Abstract]   [Full Text] [Related]  

  • 35. Production of Monoclonal Antibody Against Excretory-Secretory Antigen of Fasciola hepatica and Evaluation of Its Efficacy in the Diagnosis of Fascioliasis.
    Abdolahi Khabisi S; Sarkari B; Moshfe A; Jalali S
    Monoclon Antib Immunodiagn Immunother; 2017 Feb; 36(1):8-14. PubMed ID: 28186433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex and vaccination: Insights from female rats vaccinated with juvenile-specific proteases from Fasciola hepatica.
    Wesołowska A; Basałaj K; Norbury LJ; Sielicka A; Wędrychowicz H; Zawistowska-Deniziak A
    Vet Parasitol; 2018 May; 255():91-96. PubMed ID: 29773143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocyte responses of rats vaccinated with cDNA encoding a phosphoglycerate kinase of Fasciola hepatica (FhPGK) and F. hepatica infection.
    Wesołowska A; Zawistowska-Deniziak A; Norbury LJ; Wilkowski P; Pyziel AM; Zygner W; Wędrychowicz H
    Parasitol Int; 2018 Feb; 67(1):85-92. PubMed ID: 28385589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoprophylaxis against Fasciola hepatica in rabbits using a recombinant Fh15 fatty acid-binding protein.
    Casanueva R; Hillyer GV; Ramajo V; Oleaga A; Espinoza EY; Muro A
    J Parasitol; 2001 Jun; 87(3):697-700. PubMed ID: 11426738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD.
    Martínez-Fernández AR; Nogal-Ruiz JJ; López-Abán J; Ramajo V; Oleaga A; Manga-González Y; Hillyer GV; Muro A
    Vet Parasitol; 2004 Dec; 126(3):287-98. PubMed ID: 15567592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired resistance to Fasciola hepatica in cattle using a purified adult worm antigen.
    Hillyer GV; Haroun ET; Hernandez A; de Galanes MS
    Am J Trop Med Hyg; 1987 Sep; 37(2):363-9. PubMed ID: 3661829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.